{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T17:33:42Z","timestamp":1794677622577,"version":"4.9.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To determine the location and grade of prostate cancer diagnosed by transperineal template-guided mapping (TTMB) after negative transrectal ultrasound-guided (TRUS) biopsy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>This analysis consisted of 1118 consecutive patients who underwent TTMB from January 2005 to August 2015. Eight hundred thirty-five underwent TTMB after at least 1 negative TRUS biopsy and 283 underwent TTMB as the first biopsy procedure. The study population was divided into cohorts based on the number of prior TRUS biopsy sessions (0, 1, 2, and \u22653). No patient underwent multiparametric magnetic resonance imaging. Differences in location and cancer grade detected on TTMB were evaluated as a function of the number of prior TRUS biopsies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of the 1118 patients, 679 were diagnosed with prostate cancer. This included 208, 325, 104, and 42 patients who underwent 0, 1, 2, and \u22653 prior TRUS biopsies. The incidence of cancer detection on TTMB decreased as the number of prior TRUS biopsies increased (73.5% vs. 62.4% vs. 51.7% vs. 37.2%, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001); however, it became increasingly likely that TTMB would detect anterior prostate only as the number of prior TRUS biopsies increased (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.007). Moreover, the incidence of high grade cancer (Gleason score \u22657) in the anterior gland increased with the number of previous TRUS biopsies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>TTMB detected prostate cancer in over half of the patients with one or more negative TRUS biopsies. The majority of TTMB detected cancers were Gleason score \u22657. As the number of prior TRUS biopsies increased, there was a commensurate increase in the proportion of high-grade, anterior only disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000352","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T16:52:03Z","timestamp":1480524723000},"page":"723-729","source":"Crossref","is-referenced-by-count":20,"title":["Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy"],"prefix":"10.1097","volume":"41","author":[{"given":"Nathan","family":"Bittner","sequence":"first","affiliation":[{"name":"Tacoma\/Valley Radiation Oncology Centers, Tacoma, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Merrick","sequence":"additional","affiliation":[{"name":"Schiffler Cancer Center and Wheeling Jesuit University"},{"name":"Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al","family":"Taira","sequence":"additional","affiliation":[{"name":"Dorothy Schneider Cancer Center and Mills Peninsula Hospital, San Mateo, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbey","family":"Bennett","sequence":"additional","affiliation":[{"name":"Schiffler Cancer Center and Wheeling Jesuit University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Schattel","sequence":"additional","affiliation":[{"name":"Schiffler Cancer Center and Wheeling Jesuit University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Butler","sequence":"additional","affiliation":[{"name":"Schiffler Cancer Center and Wheeling Jesuit University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Galbreath","sequence":"additional","affiliation":[{"name":"Schiffler Cancer Center and Wheeling Jesuit University"},{"name":"Ohio University Eastern, St. Clairsville, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Adamovich","sequence":"additional","affiliation":[{"name":"Pathology, Wheeling Hospital, Wheeling WV"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.eururo.2012.05.049","article-title":"Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy","volume":"65","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.eururo.2013.01.035","article-title":"Is an initial saturation prostate biopsy scheme better than an extended scheme for detection of prostate cancer? A systematic review and meta-analysis","volume":"63","author":"Jiang","year":"2013","journal-title":"Eur Urol"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.5489\/cuaj.1248","article-title":"How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?","volume":"7","author":"Serefoglu","year":"2013","journal-title":"Can Urol Assoc J"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/pcan.2009.42","article-title":"Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting","volume":"13","author":"Taira","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.13031","article-title":"Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience","volume":"116","author":"Ong","year":"2015","journal-title":"BJU Int"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4103\/0974-7796.152052","article-title":"Significant impact of transperineal template biopsy of the prostate at a single tertiary institution","volume":"7","author":"Huang","year":"2015","journal-title":"Urol Ann"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1464-410X.2012.10972.x","article-title":"High detection rate of significant prostate tumours in the anterior zones using transperineal ultrasound-guided template saturation biopsy","volume":"110","author":"Mabjeesh","year":"2012","journal-title":"BJU Int"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1464-410X.2008.07542.x","article-title":"The morbidity of transperineal template-guided prostate mapping biopsy","volume":"101","author":"Merrick","year":"2008","journal-title":"BJU Int"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/bjc.2014.192","article-title":"Identification of pathologically insignificant prostate cancer is not accurate in unscreened men","volume":"110","author":"Shaw","year":"2014","journal-title":"Br J Cancer"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.juro.2015.02.015","article-title":"Incidence and predictors of upgrading and up staging among 10,000 contemporary patients with low risk prostate cancer","volume":"194","author":"Dinh","year":"2015","journal-title":"J Urol"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/pros.22622","article-title":"Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens","volume":"73","author":"Crawford","year":"2013","journal-title":"Prostate"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrurol.2013.195","article-title":"Transperineal biopsy of the prostate-is this the future?","volume":"10","author":"Chang","year":"2013","journal-title":"Nat Rev Urol"},{"key":"R13-20230903","first-page":"326","article-title":"The current and future role of magnetic resonance imaging in prostate cancer detection and management","volume":"4","author":"Radtke","year":"2015","journal-title":"Transl Androl Urol"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"E853","DOI":"10.5489\/cuaj.2895","article-title":"Investigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy","volume":"9","author":"Serrao","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00345-015-1749-3","article-title":"Can MRI\/TRUS fusion targeted biopsy replace saturation biopsy in the re-evaluation of men in active surveillance?","volume":"34","author":"Pepe","year":"2016","journal-title":"World J Urol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000421-201808000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T03:06:08Z","timestamp":1693710368000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201808000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000352","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}